Joana Goncalves, Chief Medical Officer at Oruka Therapeutics, Inc. (ORKA), sold 7,947 shares at $91.10 ($734K) on 2026-09-15, disclosed to the SEC on 2026-09-15.
Scheduled sale ($734k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.10 | 2,384 | $217K | 29.6% |
| 2 | $92.03 | 3,150 | $290K | 39.5% |
| 3 | $92.99 | 1,366 | $127K | 17.3% |
| 4 | $94.22 | 100 | $9K | 1.3% |
| 5 | $95.71 | 947 | $91K | 12.3% |
| Total | $92.38 avg | 7,947 |
| $734K |
| 100% |
| Filing → |
| ORKA | SELL | 2026-07-15 | $604K | — | Filing → |
| ORKA | SELL | 2026-06-15 | $551K | — | Filing → |
| ORKA | SELL | 2026-05-15 | $433K | — | Filing → |